Teri Klein

Teri E. Klein is an American professor of Biomedical Data Science and Medicine at Stanford University, with a courtesy appointment in Genetics. She is recognized for her contributions to pharmacogenomics and computational biology. Klein earned a B.A. from the University of California, Santa Cruz (1980) and a Ph.D. from the University of California, San Francisco (1987). She joined Stanford University in 2000 and holds the position of professor (research) as of 2022. Klein is a co-founder of the Pacific Symposium on Biocomputing and serves as Principal Investigator for several initiatives, including PharmGKB, the Clinical Pharmacogenomics Implementation Consortium (CPIC), The Pharmacogenomic Clinical Annotation Tool (PharmCAT), and the Clinical Genome Resource (ClinGen).

Klein has authored numerous publications in prominent scientific journals. Notable works include "Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes" (2012) in Cell, which explores personalized omics profiling, and "Pharmacogenomics Knowledge for Personalized Medicine" (2012) in Clinical Pharmacology & Therapeutics. Other significant publications include "Considerations for pharmacogenomic testing in a health system" (2019) in Genetics in Medicine and "PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge" (2021) in Current Protocols.

Klein has received several honors, including being named a fellow of the American College of Medical Informatics in 2001 and a fellow of the American Association for the Advancement of Science in 2021.